Table 6. Validation of KNN classification for predicting tissue pathological categories (including cancer stages) using epithelial cells only and Biomarkers I.

A	Classification
ID	B	ASAP	Stage II	Stage III	LAC	Total
HPrEpiC	1,798	29	49	102	88	2,066
%	87.03	1.4	2.37	4.94	4.26	100
LNCaP	128	1,070	10,775	1,587	3,877	17,437
%	0.73	6.14	61.79	9.1	22.23	100
B	Classification
ID	B	ASAP	Stage II	Stage III	LAC	Total
Patient 5	2	61	1,687	2,355	7,480	11,585
%	0.02	0.53	14.56	20.33	64.57	100
Patient Z	207	832	73	2,652	5,610	9,374
%	2.21	8.88	0.78	28.29	59.85	100
C	Classification
Phase	B	ASAP	Stage II	Stage III	LAC	Total
B1	589	202	87	1,052	789	2,719
%	21.66	7.43	3.2	38.69	29.02	100
P	437	650	74	10,270	8,691	20,122
%	2.17	3.23	0.37	51.04	43.19	100
D	Classification
ID	B	ASAP	Stage II	Stage III	LAC	Total
Patient 7	9	250	536	3,851	983	5,629
%	0.16	4.44	9.52	68.41	17.46	100
Patient 8	232	1,038	1,215	4,136	1,894	8,515
%	2.72	12.19	14.27	48.57	22.24	100